Multiple Vacancies in Marketing, Sales Officer, Area Sales Manager, Regional Sales Manager, F & D,

Posted On Jun 13 2017 by

#pharma marketing jobs # Multiple Vacancies in Marketing, Sales Officer, Area Sales Manager, Regional Sales Manager, F D, Production, QC in ORDAIN HEALTHCARE ORDAIN was created with a simple objective of providing Quality Drugs… Quality Life to all the precious human life. Our mission is to continuously innovate methods of “Preserving and improving quality of human life” by providing superior products and services with uncompromised Quality Everywhere… Every time… We are ranked 79th position in all Indian Pharmaceutical Market and 44th position in Tamilnadu in our represented markets in India by ORG-IMS. We are proud to have achieved 120th rank …


Multiple Vacancies in Marketing, Sales Officer, Area Sales Manager, Regional Sales Manager, F & D,

Posted On May 29 2017 by

#pharma marketing jobs # Multiple Vacancies in Marketing, Sales Officer, Area Sales Manager, Regional Sales Manager, F D, Production, QC in ORDAIN HEALTHCARE ORDAIN was created with a simple objective of providing Quality Drugs… Quality Life to all the precious human life. Our mission is to continuously innovate methods of “Preserving and improving quality of human life” by providing superior products and services with uncompromised Quality Everywhere… Every time… We are ranked 79th position in all Indian Pharmaceutical Market and 44th position in Tamilnadu in our represented markets in India by ORG-IMS. We are proud to have achieved 120th rank …


Onyx Pharma Releases Promising Multiple Myeloma Study Results #pharma #equipment

Posted On May 28 2017 by

#onyx pharma # Onyx Pharma Releases ‘Promising’ Multiple Myeloma Study Results Jul 26th 2010 9:00AM Onyx Pharmaceuticals (ONXX ) announced what it called “promising results” from a mid-stage study of its experimental drug carfilzomib in patients with relapsed and refractory multiple myeloma. ONXX shares soared 12% in recent premarket activity. Patients in the trial had been previously treated, but stopped responding to standard treatments. But nearly a quarter (24%) of the patients responded to carfilzomib for a median duration of 7.4 months. While this may not sound like a big advancement, such patients with the blood cancer usually respond to …


Onyx Pharma Releases Promising Multiple Myeloma Study Results #pharmaceuticals #news

Posted On May 12 2017 by

#onyx pharma # Onyx Pharma Releases ‘Promising’ Multiple Myeloma Study Results Jul 26th 2010 9:00AM Onyx Pharmaceuticals (ONXX ) announced what it called “promising results” from a mid-stage study of its experimental drug carfilzomib in patients with relapsed and refractory multiple myeloma. ONXX shares soared 12% in recent premarket activity. Patients in the trial had been previously treated, but stopped responding to standard treatments. But nearly a quarter (24%) of the patients responded to carfilzomib for a median duration of 7.4 months. While this may not sound like a big advancement, such patients with the blood cancer usually respond to …


Multiple vacancies in Teva Pharmaceutical #medicinal #chemistry

Posted On Apr 28 2017 by

#teva pharma jobs # Multiple vacancies in Teva Pharmaceutical | Production, R D, F D, QA and More. Teva Pharmaceutical Industries Lid. (NASDAQ:TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as Innovative and specialty pharmaceuticals and active pharmaceutical Ingredients. Headquartered In Israel, leva Is the world’s largest generic drug maker, with a global product portfolio of more than 1,250 molecules and a direct presence in approximately 60 countries. Teva employs about 40,000 people around the world and reached $13.9 billion in net sales in …


Multiple vacancies in Teva Pharmaceutical #industry #pharmacy

Posted On Apr 10 2017 by

#teva pharma jobs # Multiple vacancies in Teva Pharmaceutical | Production, R D, F D, QA and More. Teva Pharmaceutical Industries Lid. (NASDAQ:TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as Innovative and specialty pharmaceuticals and active pharmaceutical Ingredients. Headquartered In Israel, leva Is the world’s largest generic drug maker, with a global product portfolio of more than 1,250 molecules and a direct presence in approximately 60 countries. Teva employs about 40,000 people around the world and reached $13.9 billion in net sales in …


Multiple vacancies in Teva Pharmaceutical #csl #pharma

Posted On Mar 31 2017 by

#teva pharma jobs # Multiple vacancies in Teva Pharmaceutical | Production, R D, F D, QA and More. Teva Pharmaceutical Industries Lid. (NASDAQ:TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as Innovative and specialty pharmaceuticals and active pharmaceutical Ingredients. Headquartered In Israel, leva Is the world’s largest generic drug maker, with a global product portfolio of more than 1,250 molecules and a direct presence in approximately 60 countries. Teva employs about 40,000 people around the world and reached $13.9 billion in net sales in …


Onyx Pharma Releases Promising Multiple Myeloma Study Results #promius #pharma

Posted On Mar 29 2017 by

#onyx pharma # Onyx Pharma Releases ‘Promising’ Multiple Myeloma Study Results Jul 26th 2010 9:00AM Onyx Pharmaceuticals (ONXX ) announced what it called “promising results” from a mid-stage study of its experimental drug carfilzomib in patients with relapsed and refractory multiple myeloma. ONXX shares soared 12% in recent premarket activity. Patients in the trial had been previously treated, but stopped responding to standard treatments. But nearly a quarter (24%) of the patients responded to carfilzomib for a median duration of 7.4 months. While this may not sound like a big advancement, such patients with the blood cancer usually respond to …


Onyx Pharma Releases Promising Multiple Myeloma Study Results #crm #for #pharma

Posted On Mar 14 2017 by

#onyx pharma # Onyx Pharma Releases ‘Promising’ Multiple Myeloma Study Results Jul 26th 2010 9:00AM Onyx Pharmaceuticals (ONXX ) announced what it called “promising results” from a mid-stage study of its experimental drug carfilzomib in patients with relapsed and refractory multiple myeloma. ONXX shares soared 12% in recent premarket activity. Patients in the trial had been previously treated, but stopped responding to standard treatments. But nearly a quarter (24%) of the patients responded to carfilzomib for a median duration of 7.4 months. While this may not sound like a big advancement, such patients with the blood cancer usually respond to …


Multiple Vacancies in Marketing, Sales Officer, Area Sales Manager, Regional Sales Manager, F & D,

Posted On Dec 8 2016 by

#pharma marketing jobs # Multiple Vacancies in Marketing, Sales Officer, Area Sales Manager, Regional Sales Manager, F D, Production, QC in ORDAIN HEALTHCARE ORDAIN was created with a simple objective of providing Quality Drugs… Quality Life to all the precious human life. Our mission is to continuously innovate methods of “Preserving and improving quality of human life” by providing superior products and services with uncompromised Quality Everywhere… Every time… We are ranked 79th position in all Indian Pharmaceutical Market and 44th position in Tamilnadu in our represented markets in India by ORG-IMS. We are proud to have achieved 120th rank …